Azithromycin for Cerclage Prophylaxis
ConditionCervical Insufficiency
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18+
SponsorWake Forest University Health Sciences
About this trial
The primary goal is to assess the effectiveness in pregnancy prolongation utilizing azithromycin at the time of transvaginal cervical cerclage placement.
Eligibility criteria
Qualifiers
Singleton gestation at 16+0 to 23+6 weeks of gestational age at the time of enrollment
Indication for transvaginal cerclage placement
Intact amniotic membranes
Disqualifiers
Evidence of active infection or chorioamnionitis at presentation
Preterm prelabor rupture of membranes (PPROM)
Multiple gestation
HIV positive status
Trial design
Treatments tested in this trial
- Azithromycin Prophylaxis
- Azithromycin Placebo
- Cefazolin
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov